MarketCap
Facebook
X
Telegram
Inspire Medical Systems Income Statement 2025-2011 | INSP
Brief overview of income trends at Inspire Medical Systems
The comparison covers a five-year financial horizon. According to figures from Inspire Medical Systems, revenue changed from 115 million dollars to 912 million dollars over five years. Overall revenue changed by +690.4%, equal to an annualized rate of about 51.2%. Sales grew at a rate typical of a strong expansion phase.
Gross profit changed from $97.8 million to $779 million (+696.6%). The relationship between sales and direct costs improved over the period. The gross margin was 84.7% at the start and 85.4% at the end. The relationship between gross profit and revenue changed only slightly.
EBITDA was −55.4 million dollars at the beginning and 64.9 million dollars at the end of the period (+217.2%). EBITDA underperformed the top-line trend. EBITDA margin moved from −48% to 7.1%. The company improved its ability to convert sales into EBITDA.
Comparing the endpoints shows a move from −57.2 million dollars to 145 million dollars. The trajectory reversed from a loss to positive earnings.
Over the period, capitalization shifted from $5.3 billion to $1.8 billion (−66.5%). The market has not yet confirmed the improvement in fundamentals.
Summary assessment
The financial profile remains mixed, with strengths and risks moving in different directions. The constructive conclusion rests on consistent sales economics, higher operating efficiency and a larger revenue base. The most visible risks are declining capitalization. The next reporting periods will show whether revenue, margins, and final profitability can strengthen.
Annual Income Statement Inspire Medical Systems
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
1.76 B | 5.41 B | 5.76 B | 7.39 B | 6.03 B | 5.25 B | 1.86 B | 752 M | - | - | - | - | - | - | - |
Shares |
29.4 M | 29.8 M | 29.3 M | 28.1 M | 27.3 M | 26.1 M | 23.8 M | 14.6 M | - | - | - | - | - | - | - |
Historical Prices |
60 | 182 | 197 | 263 | 221 | 202 | 74.8 | 53.6 | - | - | - | - | - | - | - |
Net Income |
145 M | 53.5 M | -21.2 M | -44.9 M | -42 M | -57.2 M | -33.2 M | -21.8 M | -17.5 M | -18.5 M | -21.3 M | - | - | - | - |
Revenue |
912 M | 803 M | 625 M | 408 M | 233 M | 115 M | 82 M | 50.6 M | 28.6 M | 16.4 M | 8.01 M | - | - | - | - |
Cost of Revenue |
133 M | 123 M | 96.6 M | 66.1 M | 33.3 M | 17.6 M | 13.6 M | 10.1 M | 6.02 M | 3.9 M | - | - | - | - | - |
Gross Profit |
779 M | 680 M | 528 M | 342 M | 200 M | 97.8 M | 68.4 M | 40.5 M | 22.5 M | 12.5 M | 5.2 M | - | - | - | - |
Operating Income |
51 M | 36.1 M | -40.3 M | -47.6 M | -39.8 M | -56.2 M | -34.9 M | -20.4 M | -16 M | -17.3 M | - | - | - | - | - |
Interest Expense |
-2.66 M | -855 K | -195 K | -49 K | 2.13 M | 2.12 M | 2.12 M | 3.3 M | 1.75 M | 1.3 M | - | - | - | - | - |
EBITDA |
64.9 M | 42.6 M | -37.4 M | -45.7 M | -38.6 M | -55.4 M | -34.4 M | -20 M | -15.7 M | -17.2 M | -19.7 M | - | - | - | - |
Operating Expenses |
- | - | - | - | 240 M | 154 M | 103 M | 60.9 M | 38.6 M | 29.8 M | 25 M | - | - | - | - |
General and Administrative Expenses |
625 M | 530 M | 452 M | 321 M | 203 M | 128 M | 90.5 M | 53.5 M | 3.81 M | - | 2.63 M | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Inspire Medical Systems
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
29.3 M | 29.5 M | 29.7 M | 29.7 M | 29.9 M | 29.7 M | 29.6 M | 29.6 M | 29.4 M | 29.2 M | 29.1 M | 29 M | 28.2 M | 27.6 M | 27.5 M | 27.4 M | 27.3 M | 27.2 M | 27.1 M | 27.1 M | 26.8 M | 26.3 M | 24.2 M | 24.1 M | 23.9 M | 23.8 M | 23.4 M | 23.4 M | 21.4 M | 13.5 M | 1.29 M | 1.27 M | 1.18 M | 1.15 M | 1.15 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
9.93 M | -3.59 M | 2.99 M | - | 18.5 M | 9.79 M | -10 M | - | -8.54 M | -12 M | -15.4 M | - | -16.8 M | -14.5 M | -16.7 M | - | -10.3 M | -13.1 M | -16.2 M | -7.48 M | -10.4 M | -23.1 M | -16.2 M | -9.08 M | -8.25 M | -7.65 M | -8.27 M | -4.78 M | -4.69 M | -5.86 M | -6.5 M | -4.25 M | -4.02 M | -4.76 M | -4.48 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
225 M | 217 M | 201 M | - | 203 M | 196 M | 164 M | - | 153 M | 151 M | 128 M | - | 109 M | 91.4 M | 69.4 M | - | 61.7 M | 53 M | 40.4 M | 46 M | 35.8 M | 12.2 M | 21.3 M | 26.9 M | 20.9 M | 18 M | 16.2 M | 16.6 M | 13.1 M | 10.9 M | 10 M | 9.96 M | 7.27 M | 6.04 M | 5.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
31.8 M | 34.7 M | 30.7 M | - | 32.4 M | 29.8 M | 24.8 M | - | 24.4 M | 24.3 M | 19.9 M | - | 19.8 M | 14.2 M | 10 M | - | 8.62 M | 7.52 M | 5.98 M | - | 5.21 M | 1.95 M | 3.3 M | - | 3.46 M | 3.09 M | 2.85 M | - | 2.47 M | 2.1 M | 2.29 M | - | 1.56 M | 1.38 M | 1.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
193 M | 182 M | 171 M | - | 171 M | 166 M | 139 M | - | 129 M | 127 M | 108 M | - | 89.4 M | 77.2 M | 59.4 M | - | 53.1 M | 45.4 M | 34.4 M | 38.8 M | 30.6 M | 10.2 M | 18 M | 22.7 M | 17.4 M | 14.9 M | 13.4 M | 13.4 M | 10.6 M | 8.84 M | 7.75 M | 8.08 M | 5.71 M | 4.67 M | 4.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
9.64 M | -3.32 M | -1.48 M | - | 14.3 M | 5.1 M | -15.2 M | - | -13.5 M | -16.6 M | -19.5 M | - | -17.2 M | -14 M | -16.1 M | - | -9.8 M | -12.5 M | -15.7 M | - | -9.89 M | -22.8 M | -16.4 M | - | -8.65 M | -8.18 M | -8.78 M | - | -4.65 M | -5.64 M | -5.2 M | - | -3.65 M | -4.38 M | -4.12 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
-66 K | -3.5 M | 578 K | - | 118 K | -135 K | -60 K | - | -224 K | -61 K | 17 K | - | 656 K | 494 K | 527 K | - | 537 K | 530 K | 523 K | - | 533 K | 526 K | 525 K | - | 529 K | 523 K | 537 K | - | 680 K | 550 K | 1.38 M | - | 428 K | 4 K | -1 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
13.3 M | 84 K | 1.56 M | - | 16.2 M | 6.5 M | -14.4 M | - | -12.7 M | -15.9 M | -18.9 M | - | -16.7 M | -13.6 M | -15.7 M | - | -8.92 M | -12.2 M | -15.5 M | - | -9.3 M | -22.4 M | -16.3 M | - | -8.31 M | -7.97 M | -8.67 M | - | -4.36 M | -5.45 M | -5.1 M | - | -3.48 M | -4.28 M | -4.08 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | 156 M | 161 M | 154 M | - | 142 M | 143 M | 128 M | - | 107 M | 91.2 M | 75.4 M | - | 62.9 M | 58 M | 50.1 M | - | 40.5 M | 33 M | 34.5 M | - | 26.1 M | 23.1 M | 22.2 M | - | 15.2 M | 14.5 M | 12.9 M | - | 9.36 M | 9.05 M | 8.22 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
159 M | 160 M | 144 M | - | 130 M | 132 M | 126 M | - | 113 M | 113 M | 102 M | - | 85.6 M | 76.7 M | 63.6 M | - | 53.2 M | 48.7 M | 41.9 M | - | 33.2 M | 27 M | 29.1 M | - | 22.4 M | 20.3 M | 19.6 M | - | 13.5 M | 12.7 M | 11.2 M | - | 864 K | 801 K | 887 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
The income statement is one of the three key financial reports of a company Inspire Medical Systems (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
USA
France
China
Canada
Australia
Britain
Israel
